- Home
- GROW vs COEP Comparison
GROW vs COEP Comparison
Compare GROW & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- COEP
- Stock Information
- Founded
- GROW 1968
- COEP 2017
- Country
- GROW United States
- COEP United States
- Employees
- GROW N/A
- COEP N/A
- Industry
- GROW Investment Managers
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GROW Finance
- COEP Health Care
- Exchange
- GROW Nasdaq
- COEP Nasdaq
- Market Cap
- GROW 31.8M
- COEP 27.4M
- IPO Year
- GROW N/A
- COEP N/A
- Fundamental
- Price
- GROW $2.45
- COEP $10.95
- Analyst Decision
- GROW
- COEP
- Analyst Count
- GROW 0
- COEP 0
- Target Price
- GROW N/A
- COEP N/A
- AVG Volume (30 Days)
- GROW 38.8K
- COEP 56.9K
- Earning Date
- GROW 09-09-2025
- COEP 08-15-2025
- Dividend Yield
- GROW 3.67%
- COEP N/A
- EPS Growth
- GROW N/A
- COEP N/A
- EPS
- GROW 0.01
- COEP N/A
- Revenue
- GROW $8,932,000.00
- COEP $62,874.00
- Revenue This Year
- GROW N/A
- COEP N/A
- Revenue Next Year
- GROW N/A
- COEP N/A
- P/E Ratio
- GROW $233.35
- COEP N/A
- Revenue Growth
- GROW N/A
- COEP N/A
- 52 Week Low
- GROW $2.02
- COEP $2.31
- 52 Week High
- GROW $2.69
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- GROW 51.48
- COEP 59.53
- Support Level
- GROW $2.43
- COEP $11.30
- Resistance Level
- GROW $2.58
- COEP $12.71
- Average True Range (ATR)
- GROW 0.07
- COEP 0.89
- MACD
- GROW -0.01
- COEP 0.18
- Stochastic Oscillator
- GROW 43.48
- COEP 54.39
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.